aica ribonucleotide has been researched along with Familial Nonmedullary Thyroid Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrade, BM; Carvalho, DP; Cazarin, JM; Coelho, RG; Hecht, F | 1 |
1 other study(ies) available for aica ribonucleotide and Familial Nonmedullary Thyroid Cancer
Article | Year |
---|---|
5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Apoptosis; Carcinoma, Papillary; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Epithelial-Mesenchymal Transition; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Humans; Neoplasm Invasiveness; Ribonucleotides; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2016 |